Enstilar (calcipotriol and betamethasone dipropionate) is a new topical, alcohol-free, foam spray for all severities of plaque psoriasis in adults.

Manufacturer Leo says that “more than half of patients in clinical trials [experience] significant visible signs of improvement within four weeks with some patients seeing improvements at one week”. In addition, 81 per cent of psoriasis patients using Enstilar foam spray reported improved quality of life after four weeks. More than 70 per cent reported reductions in itch-related
sleep loss.

“The symptomatic relief experienced by the majority of patients may be attributed to the cooling effect of the new foam spray,” Leo says.